Mart Saarma
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Drugs targeting synaptic RNA m6A methylation regulate synaptic transmission and plasticity in the rat hippocampus.
Journal: Experimental neurology
Published: December 22, 2025
Experimental change in temperament: Conversion of the low exploratory phenotype into highly explorative by overexpression of GDNF in the rat striatum.
Journal: Molecular psychiatry
Published: December 12, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop.
Journal: Journal of Parkinson's disease
Published: February 17, 2025
RNA m6A methyltransferase activator affects anxiety-related behaviours, monoamines and striatal gene expression in the rat.
Journal: Acta neuropsychiatrica
Published: October 09, 2024
Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 16, 2024
Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease.
Journal: Neuropathology and applied neurobiology
Published: February 02, 2024
Stereocilia fusion pathology in the cochlear outer hair cells at the nanoscale level.
Journal: The Journal of physiology
Published: January 22, 2024
Brain Targeting Nanomedicines: Pitfalls and Promise.
Journal: International journal of nanomedicine
Published: December 12, 2023
CDNF and ER stress: Pharmacology and therapeutic possibilities.
Journal: Pharmacology & therapeutics
Published: October 18, 2023
Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
Journal: Nature communications
Published: December 06, 2022
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 19, 2022
Last Updated: 09/26/2026